• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Down 1%; CarMax Shares Gain After Q1 Earnings

    6/21/24 12:26:31 PM ET
    $AREB
    $CRKN
    $KAVL
    $KMX
    Plastic Products
    Industrials
    Industrial Machinery/Components
    Technology
    Get the next $AREB alert in real time by email

    U.S. stocks traded mixed midway through trading, with the Dow Jones index edging higher on Friday.

    The Dow traded up 0.02% to 39,142.01 while the NASDAQ rose 0.08% to 17,735.71. The S&P 500, however, fell 0.05% to 5,470.35.

    Check This Out: Apple To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday

    Leading and Lagging Sectors

    Communication services shares jumped by 0.7% on Friday.

    In trading on Friday, financial shares fell by 0.7%.

    Top Headline

    Shares of CarMax Inc (NYSE:KMX) gained around 2% on Friday after the company released first-quarter results.

    The company reported a first-quarter FY25 total net sales and operating revenues decline of 7.5% year-on-year to $7.11 billion, missing the analyst consensus estimate of $7.245 billion. EPS of 97 cents topped the consensus estimate 94 cents.

    Equities Trading UP
                           

    • American Rebel Holdings, Inc. (NASDAQ:AREB) shares shot up 125% to $0.6873 after the company signed a Connecticut distribution agreement with Dichello Distributors.
    • Shares of Sharecare, Inc. (NASDAQ:SHCR) got a boost, surging 78% to $1.3750 after the company agreed to be acquired by Altaris affiliate for $1.43 per share in cash.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares were also up, gaining 37% to $168.98 after the company announced FDA approval of an expansion to the labeled indication for ELEVIDYS to include individuals with Duchenne muscular dystrophy with a confirmed mutation in the DMD gene who are at least 4 years of age. Also, multiple firms raised their respective price targets on the stock.

    Equities Trading DOWN

    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares dropped 46% to $1.54 after the company announced pricing of $6.0 million public offering.
    • Shares of Crown Electrokinetics Corp. (NASDAQ:CRKN) were down 20% to $0.0401 after the company announced a 1-for-150 reverse stock split.
    • Smith & Wesson Brands, Inc. (NASDAQ:SWBI) was down, falling 12% to $14.48 after the company reported quarterly earnings.

    Also Check This Out: Top 3 Defensive Stocks That May Fall Off A Cliff This Quarter

    Commodities

    In commodity news, oil traded up 0.3% to $81.49 while gold traded down 1.1% at $2,344.00.

    Silver traded down 3.4% to $29.775 on Friday, while copper fell 2.5% to $4.4485.

    Euro zone

    European shares were lower today. The eurozone's STOXX 600 fell 0.46%, Germany's DAX fell 0.24% and France's CAC 40 fell 0.26%. Spain's IBEX 35 Index fell 0.82%, while London's FTSE 100 fell 0.16%.

    The Eurozone manufacturing PMI fell to 45.6 in June from 47.3 in May, while services PMI fell to 52.6 in June from 53.2 a month ago.

    The S&P Global UK composite PMI declined to 51.7 in June compared to 53.0 in May, while retail sales in the UK gained 2.9% month-over-month in May following a revised 1.8% fall in April. The HCOB Germany composite PMI fell to 50.6 in June compared to May’s reading of 52.4, while French composite PMI slipped to 48.2 from 48.9.

    Asia Pacific Markets

    Asian markets closed lower on Friday, with Japan's Nikkei falling 0.09%, Hong Kong's Hang Seng Index declining 1.67%, China's Shanghai Composite Index falling 0.24% and India's S&P BSE Sensex falling 0.1%.

    The annual inflation rate in Hong Kong rose to 1.2% in May from 1.1% in the prior month, while Hong Kong’s current account surplus widened to HKD 100.96 billion during the first quarter from HKD 44.43 billion in the year-ago period.

    The HSBC India Composite PMI climbed to 60.9 in June compared to 60.5 in the prior month, while au Jibun Bank Flash Japan composite PMI declined to 50.0 in June compared to 52.6 in May. The annual inflation rate in Japan rose to 2.8% in May versus 2.5% in the prior month.

    Economics

    • The S&P Global composite PMI climbed to 54.6 in June, notching its strongest level since April 2022, and compared to 54.5 in May.
    • The S&P Global U.S. services PMI surged to 55.1 in June versus 54.8 a month ago.
    • The S&P Global U.S. manufacturing PMI climbed to a three-month high level of 51.7 in June.
    • The EIA said U.S. natural-gas supplies rose 71 billion cubic feet during the week ended June 14, , compared with market estimates of a 69 billion cubic feet gain.

    Now Read This: Nvidia, Applied Materials And 2 Other Stocks Insiders Are Selling

    Get the next $AREB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AREB
    $CRKN
    $KAVL
    $KMX

    CompanyDatePrice TargetRatingAnalyst
    Sarepta Therapeutics Inc.
    $SRPT
    1/28/2026$20.00Equal Weight
    Barclays
    Sarepta Therapeutics Inc.
    $SRPT
    12/9/2025$32.00Outperform
    Wedbush
    CarMax Inc
    $KMX
    11/12/2025$28.00Underweight
    Barclays
    CarMax Inc
    $KMX
    11/10/2025$35.00Overweight → Equal-Weight
    Morgan Stanley
    CarMax Inc
    $KMX
    11/7/2025Outperform → Sector Perform
    RBC Capital Mkts
    CarMax Inc
    $KMX
    11/7/2025Buy → Hold
    Needham
    CarMax Inc
    $KMX
    11/6/2025$30.00Neutral → Underweight
    Analyst
    CarMax Inc
    $KMX
    11/6/2025Buy → Hold
    The Benchmark Company
    More analyst ratings

    $AREB
    $CRKN
    $KAVL
    $KMX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    American Rebel Light Beer and Wil Fischer Distributing Forge Powerful Missouri Partnership to Expand Distribution Footprint

    Wil Fischer's 50+ year legacy as a top Anheuser-Busch distributor will supercharge American Rebel Light Beer's expansion in Missouri. Wil Fischer Distributing adds a multi-region territory of nearly 900,000 residents and planned 2026 brand reach opportunities for American Rebel Light Beer through the iconic 9,000-seat Black Oak Amphitheater. NASHVILLE, TN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- American Rebel Beverages, a subsidiary of American Rebel Holdings, Inc. (NASDAQ:AREB), today announced a new distribution agreement with Wil Fischer Distributing, one of Missouri's largest and most respected Anheuser-Busch wholesalers. The partnership significantly expands American Rebel Light Beer's p

    2/13/26 8:00:00 AM ET
    $AREB
    Plastic Products
    Industrials

    When Everything Burned, This Champion Safe Held the Line

    After a catastrophic house fire reduced an entire home to ashes, a Champion Safe protected the irreplaceable — and proved why real fire protection matters. Provo, UT, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Champion Safe Company (championsafe.com), a premier manufacturer of high-security safes and a proud subsidiary of American Rebel Holdings, Inc. (NASDAQ:AREB), America's Patriotic Brand, today shares the remarkable story of a Champion safe that survived a catastrophic house fire, preserving irreplaceable family treasures when everything else was lost. In the middle of the night on December 11, a family woke to the unthinkable. Fire tore through their home, leaving nothing behind. Walls col

    2/12/26 8:30:00 AM ET
    $AREB
    Plastic Products
    Industrials

    CarMax Names Keith Barr as Chief Executive Officer

    CarMax, Inc. (NYSE:KMX) ("CarMax" or the "Company") today announced that Keith Barr has been appointed President and Chief Executive Officer, and a member of the Board of Directors ("the Board"), effective March 16, 2026. David McCreight, current Interim President and CEO of CarMax, will transition to his prior duties as an independent Director of the Board. Tom Folliard will remain in his role as Interim Executive Chair of the Board until the Company's Annual Meeting in June 2026, after which he is expected to resume his prior duties as non-executive Chair of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026021283385

    2/12/26 6:50:00 AM ET
    $IHG
    $KMX
    Hotels/Resorts
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations

    $AREB
    $CRKN
    $KAVL
    $KMX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREB
    $CRKN
    $KAVL
    $KMX
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by CarMax Inc

    SCHEDULE 13G - CARMAX INC (0001170010) (Subject)

    2/13/26 11:17:04 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 13F-HR filed by Sarepta Therapeutics Inc.

    13F-HR - Sarepta Therapeutics, Inc. (0000873303) (Filer)

    2/12/26 8:57:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Smith & Wesson Brands Inc.

    SCHEDULE 13G/A - SMITH & WESSON BRANDS, INC. (0001092796) (Subject)

    2/12/26 2:14:58 PM ET
    $SWBI
    Ordnance And Accessories
    Industrials

    $AREB
    $CRKN
    $KAVL
    $KMX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Oneil Mark F bought $499,807 worth of shares (10,816 units at $46.21), increasing direct ownership by 78% to 24,690 units (SEC Form 4)

    4 - CARMAX INC (0001170010) (Issuer)

    10/6/25 4:11:10 PM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Director Steenrod Mitchell D bought $91,140 worth of shares (2,000 units at $45.57), increasing direct ownership by 6% to 38,330 units (SEC Form 4)

    4 - CARMAX INC (0001170010) (Issuer)

    10/3/25 4:09:20 PM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Director Steenrod Mitchell D bought $85,137 worth of shares (1,300 units at $65.49), increasing direct ownership by 4% to 33,577 units (SEC Form 4)

    4 - CARMAX INC (0001170010) (Issuer)

    4/25/25 4:08:42 PM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $AREB
    $CRKN
    $KAVL
    $KMX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Nicaise Claude exercised 10,500 shares at a strike of $13.71 and covered exercise/tax liability with 6,780 shares, increasing direct ownership by 13% to 31,532 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    1/29/26 8:05:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Behrens M Kathleen exercised 10,500 shares at a strike of $13.71 and covered exercise/tax liability with 6,494 shares, increasing direct ownership by 2% to 197,482 units (SEC Form 4)

    4 - Sarepta Therapeutics, Inc. (0000873303) (Issuer)

    1/29/26 8:04:03 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by CEO Ross Charles Andrew Jr

    4 - AMERICAN REBEL HOLDINGS INC (0001648087) (Issuer)

    1/7/26 10:45:53 AM ET
    $AREB
    Plastic Products
    Industrials

    $AREB
    $CRKN
    $KAVL
    $KMX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays resumed coverage on Sarepta Therapeutics with a new price target

    Barclays resumed coverage of Sarepta Therapeutics with a rating of Equal Weight and set a new price target of $20.00

    1/28/26 7:19:11 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Wedbush initiated coverage on Sarepta Therapeutics with a new price target

    Wedbush initiated coverage of Sarepta Therapeutics with a rating of Outperform and set a new price target of $32.00

    12/9/25 8:53:25 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on CarMax with a new price target

    Barclays initiated coverage of CarMax with a rating of Underweight and set a new price target of $28.00

    11/12/25 8:55:29 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $AREB
    $CRKN
    $KAVL
    $KMX
    Financials

    Live finance-specific insights

    View All

    Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results

    Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2025 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 25, 2026. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its fourth quarter and full-year 2025 financial results. The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form. After register

    2/11/26 8:30:00 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sarepta Announces Positive Topline Three-Year EMBARK Results Showing ELEVIDYS Significantly Slows Disease Progression on Key Functional Measures in Ambulatory Duchenne Patients

    At a mean age of 9 years old, ELEVIDYS-treated patients achieved mean North Star Ambulatory Assessment (NSAA) scores above baseline three years after treatment (n=52) ELEVIDYS gene therapy demonstrated 70% or greater reduction in the rate of decline relative to the propensity-weighted external control group, as measured by Time to Rise (TTR) and 10-meter walk/run (10MWR). ELEVIDYS-treated patients showed an increasing treatment effect over time, with the functional gap versus the external control group significantly widening between Year 2 and Year 3 No new treatment-related safety signals were observed, consistent with the manageable safety profile observed with ELEVIDYS in ambulato

    1/26/26 8:00:00 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sarepta Therapeutics to Report 3-Year Topline Data from EMBARK Study of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy

    Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that on Monday, Jan. 26, 2026, at 8:30 am Eastern Time, the Company will host a webcast and conference call to present 3-year topline functional results from patients treated in Part 1 of EMBARK (Study 9001-301), the global, randomized placebo-controlled Phase 3 study evaluating ELEVIDYS (delandistrogene moxeparvovec-rokl) in ambulatory individuals with Duchenne muscular dystrophy who were aged four to seven at time of treatment. The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presenta

    1/23/26 4:05:00 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AREB
    $CRKN
    $KAVL
    $KMX
    Leadership Updates

    Live Leadership Updates

    View All

    CarMax Names Keith Barr as Chief Executive Officer

    CarMax, Inc. (NYSE:KMX) ("CarMax" or the "Company") today announced that Keith Barr has been appointed President and Chief Executive Officer, and a member of the Board of Directors ("the Board"), effective March 16, 2026. David McCreight, current Interim President and CEO of CarMax, will transition to his prior duties as an independent Director of the Board. Tom Folliard will remain in his role as Interim Executive Chair of the Board until the Company's Annual Meeting in June 2026, after which he is expected to resume his prior duties as non-executive Chair of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026021283385

    2/12/26 6:50:00 AM ET
    $IHG
    $KMX
    Hotels/Resorts
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations

    Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

    NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c

    10/27/25 6:10:00 PM ET
    $CAL
    $DD
    $EMN
    Shoe Manufacturing
    Consumer Discretionary
    Major Chemicals
    Industrials

    American Rebel Holdings, Inc. (NASDAQ: AREB) to Showcase America's Patriotic Beer - American Rebel Light at the Annual 2025 National Beer Wholesalers Association (NBWA) Convention in Las Vegas, Nevada

    Hall of Famer Driver Tony Stewart to Join American Rebel Light Beer Team October 13–14 for Distributor Engagement and American Rebel Brand Activation at Booth 620 NHRA Top Fuel Driver and TSR Nitro Owner to Represent American Rebel Light Beer in Continued High-Octane National Expansion NASHVILLE, TN, Oct. 09, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ:AREB) and American Rebel Beverage are proud to announce participation in the 2025 National Beer Wholesalers Association (NBWA) Annual Convention and Trade Show, taking place October 13–15 at Caesars Palace in Las Vegas. The event brings together top-tier distributors, suppliers, and industry leaders from across the count

    10/9/25 8:00:00 AM ET
    $AREB
    Plastic Products
    Industrials

    $AREB
    $CRKN
    $KAVL
    $KMX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by American Rebel Holdings Inc.

    SC 13G/A - AMERICAN REBEL HOLDINGS INC (0001648087) (Subject)

    11/14/24 3:48:04 PM ET
    $AREB
    Plastic Products
    Industrials

    Amendment: SEC Form SC 13G/A filed by Sarepta Therapeutics Inc.

    SC 13G/A - Sarepta Therapeutics, Inc. (0000873303) (Subject)

    11/13/24 10:27:59 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care